The world is eagerly waiting for corona vaccines.
Experts are now clarifying who in Germany should be vaccinated against the coronavirus first - and how many vaccinations are required.
The news ticker.
Scientists
around the
world are researching the
coronavirus *
and trying
to develop
a
vaccine *
.
But who will be vaccinated first?
According to
Federal Chancellor Angela Merkel (CDU)
, experts - for example from the
Standing Vaccination Commission
- take a position
.
(see update from November 9th, 11.30 a.m.).
The German company
Biontech
reports an effective
corona vaccine
(
see update from November 9th, 12.55 p.m.
).
Here you will find the Corona news from Germany and a map of the current infection situation.
Update from November 10th, 10:32 am
: At a joint press conference with Philipp Justus,
Vice President of Google
in Central Europe, Federal Health
Minister
Jens Spahn (CDU)
once again emphasized in his ministry in Berlin that he would be “in the next few days” contract with
BioNTech
counting
(see previous update)
.
At the moment, "questions of liability and procedural law as well as questions of price need to be clarified," said Spahn.
The EU Commission was mandated with this task: “We could have concluded the contracts nationally - the only question is whether that would have been our solidarity view in the EU, that economically not so strong EU member states would have to wait months for the vaccination doses received later than others. "
When asked, Spahn said that the federal government was assuming
"up to 100 million vaccine
doses
" of
the
Biontech Pfizer agent
to be secured for Germany.
In Berlin, Justus and Spahn presented a
cooperation between
the Federal
Ministry
of Health and the search engine on the website
gesundheit.bund.de
.
The portal has been online for a good two months and presents
“evidence-based”
and “clear” information on currently
160 diseases
, according to Spahn.
Google uses an
open interface to
place the data
prominently in its search results.
Biontech / Pfizer: Spahn wants to press for a quick delivery contract for corona vaccine from the EU
Update from November 10th, 6.59 am
: Federal
Minister of
Health
Jens Spahn (CDU *)
wants the
EU
to
sign
a delivery contract
with the German research company
Biontech
and its US partner
Pfizer
as soon as possible ("in the next few days")
of their promising
corona vaccine candidate
(see previous update)
.
So far there is only one preliminary contract with the two companies, said Spahn on Monday evening on ZDF.
"As the German health
minister, I
would
find it difficult to explain if a vaccine produced in Germany were vaccinated more quickly in other regions of the world
than in Germany itself," stressed Spahn.
The CDU politician said that the successes announced by Biontech and Pfizer were "in any case very encouraging" and made one confident.
An
effectiveness of 90 percent
is very high.
In
comparison,
a
flu vaccine is
only 50 or 60 percent effective, explained the minister.
The interview by @CHSievers with the Minister of Health @jensspahn on #Impfstrategy and #Vaccine is already in the media library: "There can be setbacks in approval" https://t.co/nPnq36S5vN
- ZDF heute journal (@heutejournal) November 9, 2020
Corona vaccine from Biontech / Pfizer: Spahn does not want to "lower the standards"
Spahn also emphasized that the requirements for the vaccine would "not be changed or scaled down".
The material has to be
"well researched"
, whatever happens.
Biontech and Pfizer vaccine candidates are subject to "the same high standards" as everyone else, "said the minister, adding that this is" very important "in order to gain people's trust in this potential vaccine.
From EU circles it was said on Monday that the European Union wanted to stick to its
previous schedule
for the approval of a corona vaccine,
despite the positive announcement from Biontech and Pfizer
.
The
European Medicines Agency Ema has to
carry out further tests, so approval in Europe is not
realistic
until
"early next year" at the
earliest
.
+
Federal Minister of Health Jens Spahn (CDU) wants to put pressure on the delivery of a corona vaccine.
© Michael Kappeler / dpa
Corona: "90 percent effective" - vaccine breakthrough in Germany?
Spahn with an emotional statement
Update, 6.46 p.m
.: Two messages caused euphoria on the international stock markets on Monday:
Joe Biden's
victory
in the US presidential election and especially the announcement by the Mainz-based pharmaceutical company
Biontech
and its US partner
Pfizer
over one to more than 90 percent effective corona vaccine caused massive increases in the stock market barometers internationally.
The
German share index
(
Dax
) climbed by almost five percent.
The shares of
Biontech
and
Pfizer
recorded significant price jumps
.
The
Dax
closed in
Frankfurt am Main
with a clear increase of 4.94 percent at the closing price on Friday.
The leading German index landed at 13,095.97 points.
The price gains in France were even more massive.
The leading French index CAC 40 climbed 7.57 percent.
The FTSE 100 also rose significantly on the London Stock Exchange.
The stock market barometer in Athens even recorded an increase of 11.46 percent.
Corona vaccine for Germany: Lauterbach - "You can call it a breakthrough without exaggeration"
Update, 3 p.m.: SPD health expert Karl Lauterbach
, often in focus in the corona crisis, commented on the reports of an effective
coronavirus vaccine from Germany
.
“Intermediate results can be called a breakthrough without exaggeration.
I never doubted that we would be vaccinated.
Now you have to hope that even very difficult courses will be prevented.
The evaluated cases do not show that, ”Lauterbach wrote on
about the announcements by the German pharmaceutical company
Biontech
.
Intermediate results can be called a breakthrough without exaggeration.
I never doubted that we would be vaccinated.
Now you have to hope that even very difficult courses will be prevented.
The evaluated cases do not show that https://t.co/ouoZxTLoZ6
- Karl Lauterbach (@Karl_Lauterbach) November 9, 2020
Corona vaccine from Germany: Health Minister Jens Spahn with an emotional statement
Update, 1.30 p.m.: Federal Minister of Health Jens Spahn (CDU) spoke about the
corona vaccine
in Berlin
.
"As of today, there will be a
vaccine
against a new virus faster
than ever before in human history,
" says Spahn in an emotional statement and clarifies: "There will be a voluntary
vaccination
, that will be a vaccination offer.
In the first few weeks and months there will not be enough vaccine for everyone who wants to be vaccinated.
That is why we have to prioritize. ”
“ Vaccination centers ”are needed, the department head continues.
There has already been an agreement with the federal states to “set up these
vaccination centers
.
"Nobody can answer the question of what amount is available and when," he said in response to a reporter question about when the majority of the population had been vaccinated so that they could feel safe.
Spahn
is on the German company
BioNTech
addressed, which had announced this Monday that his agent to 90 percent effective against the
coronavirus
was.
“The teams are in contact with all developers.
As of today, the data on effectiveness are very encouraging.
That there is a
vaccine
that works,
that's what it
looks like, "explains Spahn, and says with regard to
Biontech
:" As the German Minister of Health, I am of course very pleased that a German company first, and a German research team first, the effectiveness can prove. "
Vaccine against the coronavirus: Biontech wants approval for active ingredient against Covid-19
Update, 12.55 p.m.:
A pharmaceutical company is now on the offensive - and announces a sensational interim result for its
corona vaccine
.
Specifically: The Mainz-based pharmaceutical company
Biontech
has announced that tests have shown that its vaccination
offers
more than 90 percent protection against the
insidious lung disease Covid-19
.
That writes the news portal
n-tv.de
.
According to the report,
Biontech
and the pharmaceutical company Pfizer
want to
apply for
approval from the US FDA next week.
There are apparently no
official confirmations from authorities about the effectiveness of the
coronavirus vaccine
.
Corona vaccine for Germany: "70 percent of people have to get vaccinated"
Update, 11.30 a.m .: Prof. Dr. Gerald Haug
, President of the German Academy of Sciences Leopoldina, is now speaking in
Berlin.
"I am full of hope that we will take huge steps to defeat the pandemic in 2021," he says - Haug also announces that we will "have effective vaccines available very soon".
He cites the number of
vaccinations
required
in Germany
:
"70 percent of people have to take part and get vaccinated in
order to be highly effective," explains the expert.
There is “appropriate optimism to leave the pandemic behind us next year”, he continues and wants “to look to summer 2021 with a lot of optimism.
If everyone pulls together, we will take decisive steps by summer to leave the pandemic behind us ”.
Corona vaccination in Germany: "Vaccines will be available very soon"
Update, 11.20 a.m.:
Now is
Prof. Dr.
It is Alena Buyx's turn, the chairwoman of the German Ethics Council.
“Vaccines will be available very soon
.
Who will get it first?
In the beginning they will be scarce, ”says Buyx and explains the ethical framework for vaccinations for the German population.
The focus is on the term “solidarity”.
It's about the following:
Vaccine against the coronavirus: Experts explain the sequence for vaccinations against Sars-CoV-2
Prevention of severe (corona) cases
Protecting people at high risk
Maintaining the state functionality
The people who have the highest risk of death and severe disease need to be protected, she explains, “people with old age or a bad state of health.
She cites nursing homes as an example.
And further: “Those who stand by the sick, that is, those who work in the health service.
Employees of inpatient or outpatient facilities "
When
prioritizing the corona vaccination
, "people who are important for the community, i.e. employees of the health authorities, fire brigade, police, teachers and educators" are right at the front.
Covid-19 risk groups
and groups important for the community should be vaccinated at the same time.
To put it simply: a young nurse can be vaccinated more easily and quickly than a nursing home resident.
Chancellor Angela #Merkel wants to use an urgently awaited vaccine against #Corona to protect the health system itself.
# Doctors, # nurses and # risk groups should be vaccinated first.
#Corona vaccine https://t.co/GvOj7GkGnd pic.twitter.com/eg6kdrM2AY
- APOTHEKE ADHOC (@ApothekeAdhoc) November 8, 2020
Corona vaccine for Germany: "We are all eagerly waiting for the vaccine"
Update from November 9, 11.10 a.m.:
The federal press conference on the
corona vaccine in Germany is
running in Berlin
.
Prof. Dr. Thomas Mehrtens, Chairman of the Standing Vaccination Commission
, begins with his statement.
“We are all eagerly waiting for the vaccine.
We all have great hope in the vaccine - and rightly so.
We can only get a grip on both old and new infectious diseases if we have an effective vaccine, "said the virologist and says:" It will be a step forward if we have a vaccine available soon. "
Mostly explains the difficulties and challenges.
“We are still waiting for the results of the phase III study.
We have never looked at a vaccine that has never been approved.
For reasons that are known to everyone, this time we had to start before the vaccine was approved, "Mehrtens continues:" It will not be possible to provide a vaccine to all of our population who are willing to vaccinate from the start.
The greatest benefit for the entire population must come out of it. "
Corona vaccine for Germany: Experts comment on the federal press conference in Berlin
Update from November 9th, 10.15 a.m
.: This Monday there is news about the
corona vaccine in Germany
.
Specifically: A joint position paper will be presented at the federal press
conference
entitled: “How should access to a
Covid-19 vaccine be
regulated?” We will of course keep you up to date.
Coronavirus vaccine for Germany: New record levels of corona infections
Update from November 8, 2020:
The
coronavirus
continues to spread, on
Saturday
the
Robert Koch Institute
reported
an absolute record in Germany
with over 23,000
new infections
within 24 hours.
On
Sunday
, Angela Merkel said again, in a video for the "Open House", the Chancellor declared that the urgently awaited
vaccine will
probably first be used to protect the health system.
"The question of who will be vaccinated first is discussed with the Standing
Vaccination Commission
, the Leopoldina Science Academy and the Ethics Committee," said
Merkel
in the video in which the
Chancellor
answered public questions.
“But I think I can reveal so much that I say that right at the front are, of course, nurses, doctors and also people who belong to a
risk group
.
But then there are quite a few in our country, ”said Merkel.
It
is not yet clear
when exactly a
vaccine will be
available.
But the
federal government
hopes that the first vaccines will be approved very soon.
"Then of course there will not be enough vaccine available," said the
Chancellor
and emphasized: "Nobody will be forced to be vaccinated, it is a voluntary decision."
Preparations for a
vaccination campaign were
underway.
The
federal states
planned their own vaccination centers.
We still have to see how much
vaccine
will be available and how long this vaccine will immunize.
The central task is to make the population as a whole immune to the virus.
If 60 to 70 percent of the population are immune - due to a vaccination or an illness they have survived - the virus is "more or less defeated," said Merkel.
"Then we can lift all restrictions as well," she said.
Corona vaccine: German head of research gives harsh forecast - "Pandemic will not be defeated in 2021"
First report from October 31, 2020:
Munich / Frankfurt - Since the
coronavirus spread
around the world, scientists * have been researching the development of an effective
vaccine
at full
speed
.
The pharmaceutical company
Sanofi-Aventis is also
working on it.
In an interview with
WirtschaftsKurier
, the head of
research and development for Germany explained
which vaccines could be available, how safe they are and whether he would have himself tested.
He also described that one thing in the corona pandemic was different than usual.
Corona vaccine: three types are being worked on
In principle, three types of vaccine would be tested, as
Jochen Maas
explains:
Vaccine type | description | Experience |
---|---|---|
Live vaccines | Attenuated viruses are used as carriers of the immunizing antigen. | A high level of security through a lot of experience |
Dead vaccines | This substance only contains protein, no viruses. | There is a residual risk. |
mRNA vaccines | In the process, small pieces of genetic information are administered, which trigger the production of the antigen in the human cells. | No long-term data yet |
Even if there are different experiences, Maas makes no difference for himself personally: “I would get vaccinated with all three types.
Because if they are approved, they are also safe.
"With regard to the plans for a dead vaccine, Maas said:" If we receive approval, Sanofi will probably bring such a vaccine onto the market in the summer of next year. "An insulin filling plant in Frankfurt is already being converted for this purpose.
“We will manufacture 200 million cans per year there,” says the pharmaceutical entrepreneur.
A lot of money has to be invested in the development of a vaccine without any certainty whether the substance will even be approved by the authorities.
The
risk
that enter the company here Maas called
"exorbitantly high"
.
"So far, Sanofi has invested a three-digit million sum in research, development and testing of a vaccine without knowing whether it will work," says Maas.
Corona vaccines should remain affordable: "No company will be able to make a profit"
Still, it would regulate that prices would not go so high and that a company could make extreme profits from the vaccines.
“Governments everywhere will ensure that the vaccine
remains
affordable
and no company will be able to make a profit here.
I expect that the price for one dose will be affordable for everyone, including the poorer countries, ”Maas explained.
Even if there is great economic potential in vaccine development, the race is more collegial than hostile.
“The enemy is not the competitor, but the virus.
Everyone sees it that way.
The science and business community works together excellently across borders and continents.
The authorities and politics are also pulling along.
Everyone knows we're in the same boat.
Everyone knows that no one can produce eight billion vaccine doses alone, ”said Maas, describing the“ unique ”situation in an interview with
WirtschaftsKurier
.
Corona: far-reaching immunization not yet foreseeable - "a gigantic logistical undertaking"
While the prospects for a
vaccine
are good right now, that doesn't mean the pandemic will be over next year.
“If the vaccine is there, it is very good, but it will not improve our situation immediately.
It then has to be mass produced, bottled and distributed.
We need four to eight billion doses of vaccine worldwide, depending on whether a simple vaccination is sufficient or whether it has to be repeated.
It's a gigantic logistical undertaking,
”says Maas, describing the challenge.
Nonetheless,
widespread vaccination of
the population appears to be the only long-term effective means of ending the pandemic.
The worldwide cooperation gives hope for a cooperative, international strategy.
(lb) * Merkur.de is part of the Ippen-Digital network
List of rubric lists: © Michael Kappeler / dpa